Multicenter phase II study of the AKT inhibitor MK-2206 in...

Investigational New Drugs 2015 / 8 Vol. 33; Iss. 4

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Ma, B. B. Y., Goh, B. C., Lim, W. T., Hui, E. P., Tan, E. H., Lopes, G. de Lima, Lo, K. W., Li, L., Loong, H., Foster, N. R., Erlichman, C., King, A. D., Kam, M. K. M., Leung, S. F., Chan, K. C., Chan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0264-0
Date:
August, 2015
File:
PDF, 367 KB
english, 2015
Conversion to is in progress
Conversion to is failed